Around the Region
Cubist completes Adolor purchase
Associated Press
/
December 13, 2011
Text size
–
+
Cubist Pharmaceuticals Inc. said today that it has completed its acquisition of fellow drugmaker Adolor Corp. for about $221 million. Lexington-based Cubist said it bought all of Exton, Pa.-based Adolor’s outstanding shares for $4.25 per share in cash. Adolor shareholders will also receive up to an additional $4.50 per share if certain milestones are met in the development of a potential treatment for chronic, opioid-induced constipation, Cubist said. Effective today, Adolor common stock ceased trading on the Nasdaq stock exchange.
For more from BostonGlobe.com, sign up or log in below
To continue, please sign up or log in to BostonGlobe.com
Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com
Sign up
Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.
Are you a Boston Globe home delivery subscriber?
Get FREE access as part of your print subscription.
BostonGlobe.com subscriber
Click to continue reading this article or to log in to BostonGlobe.com.
